MediPharm Labs Inks Exclusive Supply Agreement With Germany’s STADA

Medical cannabis company MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) agreed to supply GMP-certified medical cannabis products to German pharmaceutical giant Stada Arzneimittel AG.

Under the agreement, MediPharm will also provide manufacturing, logistics, and regulatory support.

The partnership will begin in Germany, but is expected to expand to other European countries and territories where Stada has presence.

The German manufacturer sells its products in approximately 120 countries globally.

Opportunities …

Full story available on Benzinga.com

More MediPharm Labs Inks Exclusive Supply Agreement With Germany's STADA